A vaccine against nicotine addiction

Professor Jacques Kornez of the University of Lausanne to create a vaccine that limits the craving for nicotine. The vaccine is injected into the human body as a normal shot and operates throughout the year, to deny the pleasure of smoking process and saves a person from the addiction to nicotine. After administration smoking almost completely loses interest in cigarettes. The vaccine also has a therapeutic effect, and - to contribute to the restoration of the damaged cells. Scientist named vaccine CYT002 - NicQb. It creates antibodies in the blood of smokers that block nicotine in the brain. The effect is that when the cells of the human brain nicotine enters, dopamine is released (which, by acting on receptors, causes a feeling of pleasure). Due to the fact that there is a blockage of nicotine in the blood of smokers will not feel pleasure to be released as dopamine. The study was conducted over 9 months, with the participation of people who smoked daily 10 to 40 cigarettes. It was found that 60% of subjects with quit smoking, and 40% still to smoke. This test result is very positive and will be held throughout the year, and possibly longer. In the future, you can support the re-introduction of the vaccine, which is then to reduce the body's need for nicotine. The new drug is on the international market by 2010.